317 related articles for article (PubMed ID: 32698471)
1. Human Cardiac Organoids for Modeling Genetic Cardiomyopathy.
Filippo Buono M; von Boehmer L; Strang J; Hoerstrup SP; Emmert MY; Nugraha B
Cells; 2020 Jul; 9(7):. PubMed ID: 32698471
[TBL] [Abstract][Full Text] [Related]
2. Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.
Kamdar F; Klaassen Kamdar A; Koyano-Nakagawa N; Garry MG; Garry DJ
J Card Fail; 2015 Sep; 21(9):761-70. PubMed ID: 25934595
[TBL] [Abstract][Full Text] [Related]
3. Modeling acute myocardial infarction and cardiac fibrosis using human induced pluripotent stem cell-derived multi-cellular heart organoids.
Song M; Choi DB; Im JS; Song YN; Kim JH; Lee H; An J; Kim A; Choi H; Kim JC; Han C; Jeon YK; Kim SJ; Woo DH
Cell Death Dis; 2024 May; 15(5):308. PubMed ID: 38693114
[TBL] [Abstract][Full Text] [Related]
4. Human Cardiac Organoids for Disease Modeling.
Nugraha B; Buono MF; von Boehmer L; Hoerstrup SP; Emmert MY
Clin Pharmacol Ther; 2019 Jan; 105(1):79-85. PubMed ID: 30415499
[TBL] [Abstract][Full Text] [Related]
5. Generation of 3D-Multicellular Human iPSC-Heart Organoids for the Noninvasive Assessment of Cardiac Fibrosis.
Lucena-Cacace A; Tian Y; Yoshida Y
Methods Mol Biol; 2024; 2803():35-48. PubMed ID: 38676883
[TBL] [Abstract][Full Text] [Related]
6. Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies.
Ramachandra CJA; Chua J; Cong S; Kp MMJ; Shim W; Wu JC; Hausenloy DJ
Cardiovasc Res; 2021 Feb; 117(3):694-711. PubMed ID: 32365198
[TBL] [Abstract][Full Text] [Related]
7. Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes.
Eschenhagen T; Mummery C; Knollmann BC
Cardiovasc Res; 2015 Apr; 105(4):424-38. PubMed ID: 25618410
[TBL] [Abstract][Full Text] [Related]
8. Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease.
Zhu L; Liu K; Feng Q; Liao Y
Stem Cell Rev Rep; 2022 Dec; 18(8):2593-2605. PubMed ID: 35525908
[TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem cells in the inherited cardiomyopathies: From disease mechanisms to novel therapies.
Ross SB; Fraser ST; Semsarian C
Trends Cardiovasc Med; 2016 Nov; 26(8):663-672. PubMed ID: 27296521
[TBL] [Abstract][Full Text] [Related]
10. Cardiac Tissue Engineering Models of Inherited and Acquired Cardiomyopathies.
Turnbull IC; Mayourian J; Murphy JF; Stillitano F; Ceholski DK; Costa KD
Methods Mol Biol; 2018; 1816():145-159. PubMed ID: 29987817
[TBL] [Abstract][Full Text] [Related]
11. From engineered heart tissue to cardiac organoid.
Cho J; Lee H; Rah W; Chang HJ; Yoon YS
Theranostics; 2022; 12(6):2758-2772. PubMed ID: 35401829
[TBL] [Abstract][Full Text] [Related]
12. Dynamic Characterization of Structural, Molecular, and Electrophysiological Phenotypes of Human-Induced Pluripotent Stem Cell-Derived Cerebral Organoids, and Comparison with Fetal and Adult Gene Profiles.
Logan S; Arzua T; Yan Y; Jiang C; Liu X; Yu LK; Liu QS; Bai X
Cells; 2020 May; 9(5):. PubMed ID: 32456176
[TBL] [Abstract][Full Text] [Related]
13. Functional and Transcriptional Characterization of Histone Deacetylase Inhibitor-Mediated Cardiac Adverse Effects in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Kopljar I; Gallacher DJ; De Bondt A; Cougnaud L; Vlaminckx E; Van den Wyngaert I; Lu HR
Stem Cells Transl Med; 2016 May; 5(5):602-12. PubMed ID: 27034410
[TBL] [Abstract][Full Text] [Related]
14. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
[TBL] [Abstract][Full Text] [Related]
15. Engineered Heart Slice Model of Arrhythmogenic Cardiomyopathy Using Plakophilin-2 Mutant Myocytes.
Blazeski A; Lowenthal J; Wang Y; Teuben R; Zhu R; Gerecht S; Tomaselli G; Tung L
Tissue Eng Part A; 2019 May; 25(9-10):725-735. PubMed ID: 30520705
[TBL] [Abstract][Full Text] [Related]
16. Neonatal Transplantation Confers Maturation of PSC-Derived Cardiomyocytes Conducive to Modeling Cardiomyopathy.
Cho GS; Lee DI; Tampakakis E; Murphy S; Andersen P; Uosaki H; Chelko S; Chakir K; Hong I; Seo K; Chen HV; Chen X; Basso C; Houser SR; Tomaselli GF; O'Rourke B; Judge DP; Kass DA; Kwon C
Cell Rep; 2017 Jan; 18(2):571-582. PubMed ID: 28076798
[TBL] [Abstract][Full Text] [Related]
17. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
[TBL] [Abstract][Full Text] [Related]
18. Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies.
Brodehl A; Ebbinghaus H; Deutsch MA; Gummert J; Gärtner A; Ratnavadivel S; Milting H
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31489928
[TBL] [Abstract][Full Text] [Related]
19. 2-Cl-C.OXT-A stimulates contraction through the suppression of phosphodiesterase activity in human induced pluripotent stem cell-derived cardiac organoids.
Kitsuka T; Itoh M; Amamoto S; Arai KI; Oyama J; Node K; Toda S; Morita S; Nishida T; Nakayama K
PLoS One; 2019; 14(7):e0213114. PubMed ID: 31295264
[TBL] [Abstract][Full Text] [Related]
20. Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 2: Spheroids, Organoids, and Disease Modeling.
Eglen RM; Reisine T
SLAS Technol; 2019 Feb; 24(1):18-27. PubMed ID: 30798678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
